7/7/2021dMed-Clinipace Completes US$50M Series C+ Financing

7/6/2021NMPA Announces Package Insert Revision of Metoclopramide Products

7/6/2021Innovent and Laekna Enter a Partnership to Co-Develop Combo of Sinti...

7/6/2021CStone Granted Chinese IND Approval for I/O Candidate CS2006/NM21-14...

7/6/2021Y-mAbs Submits Chinese BLA for DANYELZA® (naxitamab-gqgk)

7/5/2021GSK Launches HIV Drug Dovato (dolutegravir/lamivudine) in China

7/5/2021Nicox Amends Deal with Ocumension with $2M Upfront

7/2/2021NDRC Issues the Implementation Plan for Infrastructural Building of th...

7/2/2021At A Glance: Pharmaceutical Merger Review in China

6/30/2021HUTCHMED Launches $325M Initial Public Offering in Hong Kong

6/30/2021Recent Executive Moves

6/30/2021IQVIA: Potential of Chinese Pharma Lies in the Country's Huge Patient ...

6/30/2021IQVIA: Chinese Retail Pharmacy Sales Down 1.4% in Q1/2021

6/30/2021Listed Domestic Pharma Cos See Sharp Performance Growth in Q1

6/30/2021Financial-related Company News in Brief

6/29/2021Innovent Granted Chinese Approval of TYVYT in Combo with BYVASDA as...

6/29/2021Vivoryon and Simcere Announce Licensing Deal for N3pE Amyloid-targetin...

6/28/2021WuXi STA Plans Pharmaceutical Chemical Facility in Delaware

6/28/2021PharmaDJ's China Biotech Fundraising Tracker: April 2021

6/25/2021AZ's Pulmicort, Bayer's Xarelto Among Big Losers in China's Largest Ro...

6/24/2021NMPA Issues the Provisions for Registration of Licensed Pharmacists

6/24/2021China Concludes the 5th Round of National Level VBP, Slashing Average ...

6/24/2021NMPA Revises Packages Insert of Oxiracetam Formulations and Injectable...

6/23/2021Online Platform Operator Medlive Tech Advances Plans for Hong Kong IPO

6/23/2021HUTCHMED's Orpathys Conditionally Approved in China for NSCLC

6/23/2021Innovent's Sintilimab in Combo with Chemotherapy Meets Primary Endpoin...

6/22/2021Innovent's Pemazyre (pemigatinib) Approved in Taiwan

6/22/2021Hutchmed Granted Chinese Approval of Surufatinib (Sulanda) for Advance...

6/22/2021China NMPA Approves Tislelizumab in Non-Small Cell Lung Cancer and Hep...

6/21/2021AZ/MSD Granted New Indication for Lynparza (olaparib) in China

Page:64/333 Total number of articles:9989: [First][<<] [62] [63] [64] [65] [66] [>>] [End]